ERK signalling eliminates Nanog and maintains Oct4 to drive the formative pluripotency transition

Author:

Mulas Carla123ORCID,Stammers Melanie1,Salomaa Siiri I.13ORCID,Heinzen Constanze4ORCID,Suter David M.5ORCID,Smith Austin6ORCID,Chalut Kevin J.13ORCID

Affiliation:

1. Wellcome Trust – Medical Research Council Stem Cell Institute, University of Cambridge 1 , Cambridge CB2 0AW , UK

2. Randall Centre for Cell and Molecular Biology, King's College London 2 , London SE1 1YR , UK

3. Altos Labs Cambridge Institute of Science, Granta Park 3 , Cambridge CB21 6GP , UK

4. Institute of Cell Biology and Neuroscience, Goethe University, 4 Frankfurt 60439 , Germany

5. Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL) 5 , Lausanne CH-1015 , Switzerland

6. Living Systems Institute, University of Exeter 6 , Exeter EX4 4QD , UK

Abstract

ABSTRACT Naïve epiblast cells in the embryo and pluripotent stem cells in vitro undergo developmental progression to a formative state competent for lineage specification. During this transition, transcription factors and chromatin are rewired to encode new functional features. Here, we examine the role of mitogen-activated protein kinase (ERK1/2) signalling in pluripotent state transition. We show that a primary consequence of ERK activation in mouse embryonic stem cells is elimination of Nanog, which precipitates breakdown of the naïve state gene regulatory network. Variability in pERK dynamics results in heterogeneous loss of Nanog and metachronous state transition. Knockdown of Nanog allows exit without ERK activation. However, transition to formative pluripotency does not proceed and cells collapse to an indeterminate identity. This outcome is due to failure to maintain expression of the central pluripotency factor Oct4. Thus, during formative transition ERK signalling both dismantles the naïve state and preserves pluripotency. These results illustrate how a single signalling pathway can both initiate and secure transition between cell states.

Funder

King's College London

Company of Biologists

Medical Research Council

Leverhulme Trust

European Research Council

Wellcome

Publisher

The Company of Biologists

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3